google-site-verification: googlec7193c3de77668c9.html

A new triple negative breast cancer target: Why HORMAD1 could guide treatment choices

[
A gene that is typically active only in reproductive cells may hold the key to new treatments for triple negative breast cancer, according to new research published in the journal Nature Communications. Scientists from the Breast Cancer Now Toby Robins Research Center at The Institute of Cancer Research, London (ICR) and the Breast Cancer Now Research Unit at King’s College London, have uncovered a new weakness in triple negative breast cancer linked to a gene called HORMAD1 and a way to target it.


Source link

Advertisements
Views: 2

See also  Depressive mood may sharpen self-judgment but blur social cues, analysis finds

Check Also

New insights into the evolution of a gene linked to neurodevelopmental conditions

[ DNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: …

Eczema linked to 28% higher shingles risk in UK primary care analysis

[ Credit: SHVETS production from Pexels An analysis in JDDG: Journal der Deutschen Dermatologischen Gesellschaft …

Heat anxiety: ‘This year has been the worst’

“When it’s hot the air feels different in your lungs. Your brain just starts going, …

Leave a Reply

Available for Amazon Prime
Elfbar elfx kit silver pink. elfbar elfa kit.